Macy Chan
Macy assumed the office of Medical Director at Moderna Hong Kong in March 2023.
Passionate in her pursuit of advancing public health, she aims to improve health outcomes for patients across Hong Kong and the wider APAC region.
Macy works with immunization technical advisors, medical societies, healthcare authorities and regulators, and key experts in the field to develop a better understanding of unmet medical needs, fostering collaboration to make a positive impact on healthcare.
She is committed to growing Moderna’s presence in Asia, helping the company become a leader in both prevention and treatment in the region.
Prior to Moderna, Macy worked in the pharmaceutical industry for 12 years as a Registered Public Health Nutritionist (RPHNutr) at primary care trusts and NGOs across the United Kingdom. Macy is a graduate of the University of Toronto and Queen Margaret University of Edinburgh.
Commentary
How commercial spaces must adapt to changing consumer expectations
AI, data centres, and the coming energy supercycle in Hong Kong
Reinsurance beyond borders: How Hong Kong can strengthen Asia’s risk-sharing architecture
Hong Kong hospitality insights: Robust investment, tourism expansion, and operational recovery
Hong Kong’s insurance boom is facing a financing test